ID   EL4.BU
AC   CVCL_3818
SY   EL4 BU; E.L.4-BUdr
DR   CLO; CLO_0002914
DR   ATCC; TIB-40
DR   Wikidata; Q54832233
RX   PubMed=4099030;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 12
//
RX   PubMed=4099030; DOI=10.1126/science.171.3966.75;
RA   Mohit B., Fan K.;
RT   "Hybrid cell line from a cloned immunoglobulin-producing mouse myeloma
RT   and a nonproducing mouse lymphoma.";
RL   Science 171:75-77(1971).
//